BAX and neoplasm: Otherwise, apoptotic markers (caspase 3, BAX, and P53) showed a significant decline in immunoreactivity in the tumor control group, while, showed a significant strong in immunoreactivity appeared with different treatments as compared to the tumor control group (Figures 7D–F).